North America Inadequately Controlled Type-II Diabetes Treatment Market Outlook Through 2034
Across North America, the increasing prevalence of Type-II diabetes and the growing number of patients with inadequate glycemic control are driving demand for improved treatment approaches. Sedentary lifestyles, changing dietary habits, population aging, and treatment adherence challenges are contributing to the burden of diabetes and its associated complications. In response, healthcare...
0 Commentaires 0 Parts 126 Vue